Alirocumab <i>versus</i> Evolocumab on Cardiovascular Outcomes: A Systematic Review and Meta-analysis. [PDF]
Cleto AS +3 more
europepmc +1 more source
Theoretical Cost-Effectiveness of PCSK9 Inhibitors in Stroke Due to Intracranial Atherosclerosis.
Kellogg C +20 more
europepmc +1 more source
Comparative effectiveness of cholesteryl ester transfer protein (CETP) inhibitors on cardiovascular outcomes: A comprehensive Bayesian network meta-analysis and network meta-regression. [PDF]
Khalil I +16 more
europepmc +1 more source
PCSK9 inhibitors in the management of hypercholesterolaemia after heart transplantation in the UK, a single centre observational study. [PDF]
Akhtar W +6 more
europepmc +1 more source
Evaluating fitness-for-use of electronic health records in ascertaining baseline characteristics and clinical outcomes in clinical trials: insights from the VESALIUS EHR demonstration project. [PDF]
Gouda P +10 more
europepmc +1 more source
Detection and quantification of ezetimibe and its major glucuronide in patients with hepatic impairment via liquid chromatography-tandem mass spectrometry. [PDF]
Farrera DO +5 more
europepmc +1 more source
Conundrum of Cholesterol Management and Health Implications of Low Cholesterol Levels: A Narrative Review. [PDF]
Bashyal S, Karki M, Shah D.
europepmc +1 more source
Inclisiran in Chronic Kidney Disease Patients: A Real-World Experience.
Dello Strologo A +8 more
europepmc +1 more source
Lipid-lowering therapy in patients with hypercholesterolemia in terms of the POLSCORE and SCORE2 scales. A single-center retrospective analysis. [PDF]
Rogozik JK +2 more
europepmc +1 more source
Assessing the Cost Effectiveness of an Incremental Lipid-Lowering Therapy Approach After Coronary Artery Bypass Grafting Using Nationwide Data. [PDF]
Deo SV +11 more
europepmc +1 more source

